Company intelligence / Profile preview
Stem Cell Institute Panama
- Ownership
- Private
- Employees
- ~75
- Development stage
- Commercial
Overview
Stem Cell Institute Panama operates as one of the world’s leading centers for adult stem cell therapy. It has delivered more than ~50,000 procedures to over ~13,000 patients since opening in 2006/2008. Their proprietary "Golden Cells™" mesenchymal stem cells are selected using advanced screening techniques to maximize therapeutic potential. Clinical results reported by the company include improvements in multiple sclerosis lesion size reduction and positive outcomes in rheumatoid arthritis and autism spectrum disorder patients. No serious adverse events have been reported across their large patient cohort.
- Therapeutic areas
- ImmunologyOtherPsychiatryRheumatologyNeurology
- Modalities
- Stem cell therapyCell therapyBiologic (specifically mesenchymal stem cells)
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Stem Cell Institute Panama.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Stem Cell Institute Panama.